Education
About Us
Working with TipRanks
Follow Us
Dean Y Li Insider Profile
11 Followers
Dean Y Li, Executive VP & President, MRL at Merck & Company, holds 92.03K shares in Merck & Company (Ticker: MRK), holds 3.22M shares in Recursion Pharmaceuticals (Ticker: RXRX). Most recently, Dean Y Li Sold ― shares of Merck & Company on Feb 10, 2026 for an estimated value of $1.20M.
Dean Y Li Merck & Company (MRK)Executive VP & President, MRL
Merck & Company (MRK)
Executive VP & President, MRL
Ranked #41,292 out of 106,131 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+7.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dean Y Li holds in companies
Most Profitable Insider Trade
The most profitable trade made by Dean Y Li
Dean Y Li's Trading History
Merck & Company
Feb 10, 2026
Executive VP & President, MRL
Informative Sell
1.20M
$11.07M
Recursion Pharmaceuticals
Jan 06, 2026
Director
Uninformative Buy
―
$11.72M
List of latest transactions for each holding click on a transaction to see Dean Y Li's performance on stock
You May Also Like
Dean Y Li insider profile FAQ
What is the percentage of profitable transactions made by Dean Y Li?
The percentage of profitable transactions made by Dean Y Li is 33%.
What is the average return per transaction made by Dean Y Li?
The average return per transaction made by Dean Y Li is 7.50%.
What stocks does Dean Y Li hold?
Dean Y Li holds: MRK, RXRX stocks.
What was Dean Y Li’s latest transaction?
Dean Y Li latest transaction was an Informative Sell of $1.20M.
What was Dean Y Li's most profitable transaction?
Dean Y Li’s most profitable transaction was an Informative Sell of MRK stock on February 12, 2024. The return on the trade was 29.70%.
What is Dean Y Li's role in Merck & Company?
Dean Y Li's role in Merck & Company is Executive VP & President, MRL.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.